Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together.
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. more
| Time Frame | HQL | S&P500 |
|---|---|---|
| 1-Week Return | 3.97% | -0.31% |
| 1-Month Return | -1% | -1.99% |
| 3-Month Return | -2.95% | -1.32% |
| 6-Month Return | 18.54% | 4.02% |
| 1-Year Return | 28.35% | 21.01% |
| 3-Year Return | 23.89% | 75.88% |
| 5-Year Return | -16.75% | 74.21% |
| 10-Year Return | -3.18% | 240.86% |
| Time Frame | HQL | S&P500 |
|---|---|---|
| 1-Week Return | 661.44% | -14.95% |
| 1-Month Return | -11.51% | -21.69% |
| 3-Month Return | -11.44% | -5.25% |
| 6-Month Return | 41.18% | 8.32% |
| 1-Year Return | 28.35% | 21.01% |
| 3-Year Return | 7.40% | 20.71% |
| 5-Year Return | -3.60% | 11.74% |
| 10-Year Return | -0.32% | 13.05% |
| Sector | Weight |
|---|---|
|
Financials | 100.00% |
Tekla Life Sciences Investors (HQL) share price today is $16.75.
Yes, Indians can buy shares of Tekla Life Sciences Investors (HQL) on Vested. To buy HQL from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Tekla Life Sciences Investors (HQL) on Vested. You can start investing in Tekla Life Sciences Investors (HQL) with a minimum investment of $1.
The 52-week high price of Tekla Life Sciences Investors (HQL) is $17.13. The 52-week low price of Tekla Life Sciences Investors (HQL) is $9.28.
The stock symbol (or ticker) of Tekla Life Sciences Investors is HQL.
Yes, you can setup SIP in Tekla Life Sciences Investors shares. Follow the below steps to create the SIP:
Here is the historical performance of HQL on the Vested app.
The expense ratio of Tekla Life Sciences Investors (HQL) is .
Link copied